TrialPalliative medicine2026

A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study).

Hanna Hirschinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.